Chemoembolization or Bland Embolization for Hepatocellular Carcinoma: The Question Is Still Unanswered

Affiliations

Comment

Mathieu Boulin et al. J Clin Oncol. 2017.

. 2017 Jan 10;35(2):256-257.

doi: 10.1200/JCO.2016.67.2915. Epub 2016 Oct 23.

¹ Mathieu Boulin, University Hospital, Dijon, France; and Boris Guiu, Saint-Eloi University Hospital, Montpellier, France.

No abstract available

Comment in

Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.
Brown KT, Do R, Gönen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson K, Garcia AR, Beattie CM, Zhao B, Solomon SB, Schwartz LH, DeMatteo RP, Abou-Alfa GK. Brown KT, et al. J Clin Oncol. 2017 Jan 10;35(2):258-259. doi: 10.1200/JCO.2016.69.7961. Epub 2016 Oct 23. J Clin Oncol. 2017. PMID: 28056199 No abstract available.

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Brown KT, Do RK, Gonen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson KN, Garcia AR, Beattie C, Zhao B, Solomon SB, Schwartz LH, DeMatteo R, Abou-Alfa GK. Brown KT, et al. J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1. J Clin Oncol. 2016. PMID: 26834067 Free PMC article. Clinical Trial.